Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib Combinations in HER2+ Metastatic Breast Cancer
NCT01050322Phase 2Completed
- Sponsor
- Latin American Cooperative Oncology Group
- Start
- Nov 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by Latin American Cooperative Oncology Group. Started Nov 2009; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01050322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01050322.